Category Archives: News and Events

BriaCell to Present Encouraging Clinical Data at AACR 2018

– Early Evidence of Safety and Impressive Anti-Tumor Activity of Bria-IMT™- BERKELEY, Calif. and VANCOUVER, ...

BriaCell’s Lead Product Candidate Mechanism of Action Described in a Major Immunology Journal

BERKELEY, Calif. and VANCOUVER, British Columbia, April 3, 2018 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...

BriaCell Completes Previously Announced Oversubscribed Non-Brokered Private Placement and Concurrent Investment with Leading U.S. Biotech Funds

BERKELEY, Calif. and VANCOUVER, British Columbia, March 27, 2018 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Appoints Top Social Media Marketing Analyst

BERKELEY, Calif. and VANCOUVER, British Columbia, March 14, 2018 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...

BriaCell Announces Proposed Investment by Leading Biotech Funds and Concurrent Non-Brokered Financing for aggregate gross proceeds of up to $4.8 Million

BERKELEY, Calif. and VANCOUVER, British Columbia, March 07, 2018 –BriaCell Therapeutics Corp. (“BriaCell” or the ...

BriaCell To Present at Precision Breast Cancer Conference

BERKELEY, Calif. and VANCOUVER, British Columbia, March 1, 2018 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...

BriaCell to Attend 20th Annual BIO CEO & Investor Conference

BERKELEY, Calif. and VANCOUVER, British Columbia, February 7, 2018 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...

BriaCell Opens Fourth Clinical Site in Advanced Breast Cancer

BERKELEY, Calif. and VANCOUVER, British Columbia, February 6, 2018 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...

BriaCell Presenting at Upcoming Cancer Conference

– Further Investigation on Mechanism of Action of its Lead Drug Candidate, Bria-IMT™, at AACR ...

BriaCell Update: Early Evidence of Efficacy and Safety of Bria-IMT™

BERKELEY, Calif. and VANCOUVER, British Columbia, January 31, 2018 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...